A new method to evaluate central sensitization to pain following surgery. Effect of ketamine.
Stubhaug
A
A
Dept. of Anaesthesiology, Rikshospitalet, University of Oslo, Norway.
D000200:Action Potentials / Q000187:drug effects; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000771:Anesthesia, Intravenous; D000778:Anesthetics, Dissociative / Q000008:administration & dosage* / Q000494:pharmacology; D062109:Dermatologic Surgical Procedures; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology* / Q000503:physiopathology; D007649:Ketamine / Q000008:administration & dosage* / Q000494:pharmacology; D009020:Morphine / Q000627:therapeutic use; D009392:Nephrectomy; D009412:Nerve Fibers / Q000187:drug effects / Q000502:physiology; D009619:Nociceptors / Q000187:drug effects / Q000503:physiopathology*; D017288:Pain Threshold; D010149:Postoperative Pain / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010919:Placebos; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012867:Skin / Q000503:physiopathology; D014110:Touch / Q000502:physiology
D000701:Analgesics, Opioid; D000778:Anesthetics, Dissociative; D010919:Placebos; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D009020:Morphine